Updates

September 2021
HSP Concludes Biosecurity Champions Fellowship 2021
April 2021
How Embassies Are Tackling COVID-19 Vaccinations-Devex
Company At Heart Of J&J Vaccine Woes Has Series Of Citations-The Associated Press
Pfizer COVID-19 Shot 91% Effective In Updated Data, Protective Against South African Variant-Reuters
The U.S. Government Doesn’t Have Patent Rights To Gilead’s Remdesivir, Despite Investing Millions In Research-STAT
Theory That COVID Came From A Chinese Lab Takes On New Life In Wake Of WHO Report-NPR
March 2021
A Dangerous Coronavirus Variant Is Wreaking Havoc In Parts Of Europe. Experts Fear US Could Be Next-CNN
U.S. Companies Add Most Jobs Since September, ADP Data Show-Bloomberg
T Cells Induced By COVID-19 Infection Respond To New Virus Variants-Reuters
14 Countries Voice Concern Over Independence Of WHO's COVID-19 Study-Devex
Pfizer Says COVID-19 Vaccine Shows '100% Efficacy' In Adolescents-NPR
Mutations Could Render Current Covid Vaccines Ineffective In A Year Or Less, Epidemiologists Warn-CNBC
Why Indoor Spaces Are Still Prime COVID Hotspots-Nature
Vital To A Clean World, Scavengers Left To Plead For Vaccine-The Associated Press
Data Withheld From WHO Team Probing COVID-19 Origins In China-Reuters
Should Masking Last Beyond The Pandemic? Flu And Colds Are Down, Spurring A Debate-NPR
Pandemic Masks Ongoing Child Abuse Crisis As Cases Plummet-The Associated Press
Biden Admin Remakes Vaccine Strategy After Mass Vaccination Sites Fizzle-Politico
J&J, African Union In Deal For Up To 400 Million COVID-19 Shots-Reuters
‘Real World’ Study By CDC Shows Pfizer And Moderna Vaccines Were 90% Effective-STAT
Showing page   of 70